PEX Performance — ProShares Global Listed Private Equity ETF
Data updated: 2026-08-14
PEX returned −10.22% year to date and −10.53% over one year to May 2026. Annualised returns are +5.14% over 3 years and −0.33% over 5 years. The fund trailed its Global Financials Equity category average: $100 invested three years ago grew to $116, against $170 for the category, and to $89 over one year, against $109. Volatility over the past three years was 13.80% a year. In the 12 months to May 2026 the fund took in a net $309K, and assets reached $11.12M.
PEX Growth of $100
What $100 invested in ProShares Global Listed Private Equity ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Financials Equity category average over the same months.
| Period | PEX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $89 | $109 |
| 3 years (Jun 2023 – May 2026) | $116 | $170 |
| 5 years (Jun 2021 – May 2026) | $98 | $146 |
| Since data start (Sep 2019 – May 2026) | $127 | $195 |
PEX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −10.22% |
| 1 year | −10.53% |
| 3 years (annualised) | +5.14% |
| 5 years (annualised) | −0.33% |
PEX Annual Returns
Calendar-year total returns of ProShares Global Listed Private Equity ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | −10.22% |
| 2025 | +1.18% |
| 2024 | +12.46% |
| 2023 | +22.95% |
| 2022 | −25.58% |
| 2021 | +27.41% |
| 2020 | −0.60% |
| 2019 (Sep–Dec) | +7.62% |
PEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.1% | −7.9% | −7.5% | +8.4% | −2.7% | — | — | — | — | — | — | — |
| 2025 | +4.4% | +0.3% | −5.2% | −0.3% | +2.6% | +3.8% | −0.3% | +0.8% | −2.9% | −0.8% | −2.4% | +1.7% |
| 2024 | +1.4% | 0.0% | +4.3% | 0.0% | +2.9% | −1.3% | +2.0% | −0.5% | +1.9% | −2.3% | +4.6% | −0.9% |
| 2023 | +8.7% | +0.4% | −3.7% | +3.2% | −0.4% | +3.4% | +2.9% | −1.9% | −1.7% | −5.8% | +10.9% | +6.0% |
| 2022 | −5.8% | −3.7% | +1.0% | −8.1% | −1.5% | −10.6% | +9.9% | −6.9% | −13.3% | +8.6% | +8.5% | −4.0% |
| 2021 | −0.1% | +6.6% | +4.3% | +6.4% | +2.5% | −1.2% | +3.9% | +1.3% | −2.0% | +3.7% | −4.4% | +4.1% |
| 2020 | −0.1% | −10.5% | −30.6% | +12.8% | +7.9% | +0.5% | +3.2% | +6.5% | −1.7% | −3.8% | +19.5% | +5.5% |
| 2019 | — | — | — | — | — | — | — | — | +3.3% | 0.0% | +1.4% | +2.7% |
PEX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.80%
- 3-year Sharpe ratio: 0.05 (vs 4.5% risk-free rate)
- Best month: +10.93% (Nov 2023)
- Worst month: −7.86% (Feb 2026)
PEX Fund Flows
Monthly money in and out of ProShares Global Listed Private Equity ETF, from SEC Form N-PORT.
- 12-month net flow: $309K
- 12-month gross sales (incl. reinvestments): $2.8M
- Sales ÷ redemptions: 1.13×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $435K | −$435K |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $1.1M | $0 | $1.1M |
| Feb 2026 | $0 | $964K | −$964K |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $514K | −$514K |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $555K | $0 | $555K |
| Jul 2025 | $1.1M | $0 | $1.1M |
| Jun 2025 | $0 | $553K | −$553K |
PEX Assets Under Management
Net assets of ProShares Global Listed Private Equity ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $11.12M |
| 2026-02-28 | $10.72M |
| 2025-11-30 | $12.95M |
| 2025-08-31 | $14.83M |
| 2025-05-31 | $13.54M |
| 2025-02-28 | $14.17M |
| 2024-11-30 | $12.98M |
| 2024-08-31 | $10.99M |
| 2024-05-31 | $10.87M |
| 2024-02-29 | $8.28M |
| 2023-11-30 | $7.96M |
| 2023-08-31 | $8.69M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.